BMP2 Protéines
(Bone Morphogenetic Protein 2 (BMP2))
The protein encoded by this gene belongs to the transforming growth factor-beta (TGFB) superfamily. The encoded protein acts as a disulfide-linked homodimer and induces bone and cartilage formation. [provided by RefSeq, Jul 2008].
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| BMP2 Protein (AA 283-396) | Humain | Escherichia coli (E. coli) |
|
669,64 €
Voir le prix
|
|
| BMP2 Protein (AA 283-396) (Fc Tag) | Humain | HEK-293 Cells |
|
831,38 €
Voir le prix
|
|
| BMP2 Protéine | Humain | Escherichia coli (E. coli) |
|
918,62 €
Voir le prix
|
|
| BMP2 Protein (AA 283-396) | Humain, Rat, Chien, Souris, Macaque rhésus | Escherichia coli (E. coli) |
|
314,48 €
Voir le prix
|
|
| BMP2 Protein (Homodimer) | Humain, Rat, Souris | Escherichia coli (E. coli) |
172,31 €
Voir le prix
|
||
| BMP2 Protein (AA 231-330) (GST tag) | Humain | Wheat germ |
|
624,00 €
Voir le prix
|
|
| BMP2 Protein (AA 1-396) (GST tag) | Humain | Wheat germ |
|
624,00 €
Voir le prix
|
|
| BMP2 Protein (AA 283-396) (GST tag) | Humain | Wheat germ |
|
624,00 €
Voir le prix
|
|
| BMP2 Protein (AA 289-396, Extracellular Domain, N-Term) (Fc Tag) | Humain | CHO Cells |
|
615,69 €
Voir le prix
|
|
| BMP2 Protein (AA 289-396, C-Term) (His tag) | Humain | Escherichia coli (E. coli) |
|
745,73 €
Voir le prix
|
|
| BMP2 Protéine | Humain | – |
|
117,19 €
Voir le prix
|
|
| BMP2 Protein (AA 283-396) | Humain, Rat, Souris | Escherichia coli (E. coli) |
|
618,15 €
Voir le prix
|
|
| BMP2 Protéine | Humain, Rat, Souris | Escherichia coli (E. coli) |
|
2.838,46 €
Voir le prix
|
|
| BMP2 Protein (His tag) | Humain | Escherichia coli (E. coli) |
|
278,46 €
Voir le prix
|
|
| BMP2 Protein (AA 281-394) (His tag) | Souris | Escherichia coli (E. coli) |
|
840,00 €
Voir le prix
|
|
| BMP2 Protein (AA 219-350) (His tag) | Chien | Escherichia coli (E. coli) |
|
855,26 €
Voir le prix
|
|
| BMP2 Protein (AA 24-396) (His tag) | Humain | Escherichia coli (E. coli) |
|
738,89 €
Voir le prix
|
|
| BMP2 Protein (AA 283-396) (His tag,GST tag) | Humain | Escherichia coli (E. coli) |
|
738,89 €
Voir le prix
|
|
| BMP2 Protein (AA 117-267) (His tag) | Porc | Escherichia coli (E. coli) |
|
778,95 €
Voir le prix
|
|
| BMP2 Protein (AA 96-386) (His tag) | Poisson zèbre (Danio rerio) | Escherichia coli (E. coli) |
|
840,00 €
Voir le prix
|
Protein
- SDS (SDS-PAGE: Image de validation disponible)
- AcA (Activity Assay: Image de validation disponible)
15 références - Origine
- Humain
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- > 95 % as analyzed by non-reducing SDS-PAGE.
- Activité biologique
- Active
Protein
- SDS (SDS-PAGE: Image de validation disponible)
- AM (Affinity Measurement: Application indiquée)
- ADA (Antibody Drug Assay: Application indiquée)
- IA (Immunoassay: Application indiquée)
- ScA (Screening Assay: Application indiquée)
- Origine
- Humain
- Hôte
- HEK-293 Cells
- Type Proteine
- Recombinant
- Pureté
- The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
Protein
- SDS (SDS-PAGE: Image de validation disponible)
- AM (Affinity Measurement: Application indiquée)
- ADA (Antibody Drug Assay: Application indiquée)
- IA (Immunoassay: Application indiquée)
- ScA (Screening Assay: Application indiquée)
- Origine
- Humain
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- Greater than 95 % as determined by reducing SDS-PAGE.
Protein
- SDS (SDS-PAGE: Image de validation disponible)
- Origine
- Humain, Rat, Chien, Souris, Macaque rhésus
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- > 95 % as determined by Bis-Tris PAGE
- Activité biologique
- Active
Protein
- Origine
- Humain, Rat, Souris
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- > 95 % by SDS-PAGE
- Activité biologique
- Active
Protein
- AP (Affinity Purification: Application indiquée)
- AA (Antibody Array: Application indiquée)
- ELISA (ELISA: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Origine
- Humain
- Hôte
- Wheat germ
- Type Proteine
- Recombinant
Protein
- AP (Affinity Purification: Application indiquée)
- AA (Antibody Array: Application indiquée)
- ELISA (ELISA: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Origine
- Humain
- Hôte
- Wheat germ
- Type Proteine
- Recombinant
Protein
- AP (Affinity Purification: Application indiquée)
- AA (Antibody Array: Application indiquée)
- ELISA (ELISA: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Origine
- Humain
- Hôte
- Wheat germ
- Type Proteine
- Recombinant
Protein
- Origine
- Humain
- Hôte
- CHO Cells
- Type Proteine
- Recombinant
- Pureté
- >98 % (SDS-PAGE)
- Activité biologique
- Active
Protein
- Origine
- Humain
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- >95 % (SDS-PAGE)
Protein
- BCA (Biochemical Assay: Application indiquée)
- Origine
- Humain
- Type Proteine
- Recombinant
Protein
- WB (Western Blotting: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Origine
- Humain, Rat, Souris
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- Greater than 95 % as determined by SDS-PAGE.
Protein
- Origine
- Humain, Rat, Souris
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- > 95 % by SDS-PAGE
- Activité biologique
- Active
Protein
- WB (Western Blotting: Application indiquée)
- Origine
- Humain
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- >95 %
- Activité biologique
- Active
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- PC (Positive Control: Application indiquée)
- Origine
- Souris
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- > 97 %
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- PC (Positive Control: Application indiquée)
- Origine
- Chien
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- > 95 %
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- PC (Positive Control: Application indiquée)
- Origine
- Humain
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- > 90 %
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- PC (Positive Control: Application indiquée)
- Origine
- Humain
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- > 80 %
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- PC (Positive Control: Application indiquée)
- Origine
- Porc
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- > 97 %
Protein
- SDS (SDS-PAGE: Application indiquée)
- WB (Western Blotting: Application indiquée)
- Imm (Immunogen: Application indiquée)
- PC (Positive Control: Application indiquée)
- Origine
- Poisson zèbre (Danio rerio)
- Hôte
- Escherichia coli (E. coli)
- Type Proteine
- Recombinant
- Pureté
- > 80 %
Dernières publications pour nos BMP2 Protéines
: "Heterologous Secretory Expression and Characterization of Dimerized Bone Morphogenetic Protein 2 in Bacillus subtilis." dans: BioMed research international, Vol. 2017, pp. 9350537, (2018) (PubMed).
: "Hollow hydroxyapatite microspheres/chitosan composite as a sustained delivery vehicle for rhBMP-2 in the treatment of bone defects." dans: Journal of materials science. Materials in medicine, Vol. 26, Issue 1, pp. 5336, (2015) (PubMed).
: "Functionalization of titanium implants using a modular system for binding and release of VEGF enhances bone-implant contact in a rodent model." dans: Journal of clinical periodontology, Vol. 42, Issue 3, pp. 302-10, (2015) (PubMed).
: "Osteogenic differentiation and proliferation of bone marrow-derived mesenchymal stromal cells on PDLLA?+?BMP-2-coated titanium alloy surfaces." dans: Journal of biomedical materials research. Part A, (2015) (PubMed).
: "BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation." dans: Journal of cancer research and clinical oncology, Vol. 141, Issue 6, pp. 1013-24, (2015) (PubMed).
: "Release and bioactivity of bone morphogenetic protein-2 are affected by scaffold binding techniques in vitro and in vivo." dans: Journal of controlled release : official journal of the Controlled Release Society, Vol. 197, pp. 148-57, (2014) (PubMed).
: "Improved anchorage of Ti6Al4V orthopaedic bone implants through oligonucleotide mediated immobilization of BMP-2 in osteoporotic rats." dans: PLoS ONE, Vol. 9, Issue 1, pp. e86151, (2014) (PubMed).
: "Controlled-release of bone morphogenetic protein-2 from a microsphere coating applied to acid-etched Ti6AL4V implants increases biological bone growth in vivo." dans: Journal of orthopaedic research : official publication of the Orthopaedic Research Society, Vol. 32, Issue 6, pp. 744-51, (2014) (PubMed).
: "Segmental mandibular bone reconstruction with a carbonate-substituted hydroxyapatite-coated modular endoprosthetic poly(?-caprolactone) scaffold in Macaca fascicularis." dans: Journal of biomedical materials research. Part B, Applied biomaterials, Vol. 102, Issue 5, pp. 962-76, (2014) (PubMed).
: "Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(?-amino ester) porogen." dans: Acta biomaterialia, Vol. 10, Issue 5, pp. 2125-32, (2014) (PubMed).
: "Hollow hydroxyapatite microspheres/chitosan composite as a sustained delivery vehicle for rhBMP-2 in the treatment of bone defects." dans: Journal of materials science. Materials in medicine, Vol. 26, Issue 1, pp. 5336, (2015) (PubMed).
: "Functionalization of titanium implants using a modular system for binding and release of VEGF enhances bone-implant contact in a rodent model." dans: Journal of clinical periodontology, Vol. 42, Issue 3, pp. 302-10, (2015) (PubMed).
: "Osteogenic differentiation and proliferation of bone marrow-derived mesenchymal stromal cells on PDLLA?+?BMP-2-coated titanium alloy surfaces." dans: Journal of biomedical materials research. Part A, (2015) (PubMed).
: "BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation." dans: Journal of cancer research and clinical oncology, Vol. 141, Issue 6, pp. 1013-24, (2015) (PubMed).
: "Release and bioactivity of bone morphogenetic protein-2 are affected by scaffold binding techniques in vitro and in vivo." dans: Journal of controlled release : official journal of the Controlled Release Society, Vol. 197, pp. 148-57, (2014) (PubMed).
: "Improved anchorage of Ti6Al4V orthopaedic bone implants through oligonucleotide mediated immobilization of BMP-2 in osteoporotic rats." dans: PLoS ONE, Vol. 9, Issue 1, pp. e86151, (2014) (PubMed).
: "Controlled-release of bone morphogenetic protein-2 from a microsphere coating applied to acid-etched Ti6AL4V implants increases biological bone growth in vivo." dans: Journal of orthopaedic research : official publication of the Orthopaedic Research Society, Vol. 32, Issue 6, pp. 744-51, (2014) (PubMed).
: "Segmental mandibular bone reconstruction with a carbonate-substituted hydroxyapatite-coated modular endoprosthetic poly(?-caprolactone) scaffold in Macaca fascicularis." dans: Journal of biomedical materials research. Part B, Applied biomaterials, Vol. 102, Issue 5, pp. 962-76, (2014) (PubMed).
: "Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(?-amino ester) porogen." dans: Acta biomaterialia, Vol. 10, Issue 5, pp. 2125-32, (2014) (PubMed).
Pseudonymes pour BMP2 Protéines
bone morphogenetic protein 2 (BMP2) Protéinesbone morphogenetic protein 2 (Bmp2) Protéines
bone morphogenetic protein 2 L homeolog (bmp2.L) Protéines
bone morphogenetic protein 2 (bmp2) Protéines
Bone morphogenetic protein 2 (bmp2) Protéines
bone morphogenetic protein 2a (bmp2a) Protéines
AI467020 Protéines
BDA2 Protéines
BMP-2 Protéines
BMP2 Protéines
bmp2 Protéines
BMP2A Protéines
Bmp2a Protéines
bmp2a Protéines
wu:fc59d09 Protéines
xBMP-2 Protéines
xbmp2 Protéines
Avez-vous cherché autre chose?
- BMP15 Protéines
- BMP10 Protéines
- BMP1 Protéines
- BMP and Activin Membrane-Bound Inhibitor Homolog Protéines
- BMI1 Polycomb Ring Finger Oncogene Protéines
- BMF Protéines
- BLVRB Protéines
- Blood Vessel Epicardial Substance Protéines
- Block of Proliferation 1 Protéines
- BLOC1S4 Protéines
- BLOC1S3 Protéines
- BLOC1S2 Protéines
- BLOC1S1 Protéines
- BLMH Protéines
- BLM Protéines
- BLK Protéines
- BLID Protéines
- Bladder Cancer Associated Protein Protéines
- BIRC3 Protéines
- BIRC2 Protéines
- BMP2K Protéines
- BMP3 Protéines
- BMP4 Protéines
- BMP5 Protéines
- BMP6 Protéines
- BMP7 Protéines
- BMP8A Protéines
- BMP8B Protéines
- BMPER Protéines
- BMPR1B Protéines
- BMPR2 Protéines
- BMX Protéines
- BNIP1 Protéines
- BNIP2 Protéines
- BNIP3L/NIX Protéines
- BNIPL Protéines
- BNP Protéines
- BOC Protéines
- BOD1 Protéines
- BOK Protéines
Vous êtes ici:
